is still taking it though bupropion was discontinued. Ropinirole is a non-ergoline dopamine agonist that is a common antiparkinsonian drug that is also indicated for restless leg syndrome. It acts directly on the postsynaptic striatal receptors, allowing for more dopamine to be in the synaptic cleft by reducing turnover of the neurotransmitter (Murdoch, Cheer, & Wagstaff, 2004). Ropinirole focuses mostly on stimulating D2 and D3 receptors with little activity on other receptors, leading to fewer side effects (Murdoch et al., 2004). The most common side effects include nausea, dizziness, headache, constipation, abdominal pain or discomfort, and drowsiness (U.S. Food and Drug Administration, 2008). It is unclear whether J.D. will continue on this medication now that she is no longer on the bupropion and it is something that will be explored with her
is still taking it though bupropion was discontinued. Ropinirole is a non-ergoline dopamine agonist that is a common antiparkinsonian drug that is also indicated for restless leg syndrome. It acts directly on the postsynaptic striatal receptors, allowing for more dopamine to be in the synaptic cleft by reducing turnover of the neurotransmitter (Murdoch, Cheer, & Wagstaff, 2004). Ropinirole focuses mostly on stimulating D2 and D3 receptors with little activity on other receptors, leading to fewer side effects (Murdoch et al., 2004). The most common side effects include nausea, dizziness, headache, constipation, abdominal pain or discomfort, and drowsiness (U.S. Food and Drug Administration, 2008). It is unclear whether J.D. will continue on this medication now that she is no longer on the bupropion and it is something that will be explored with her